Clinical Trial Update: Evaluation of Oral Alpha-Cyclodextrin for Decreasing Serum Cholesterol [Phase 2]

View source ↗

Summary

Phase 2 results for oral alpha-cyclodextrin aimed at lowering serum cholesterol have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease

Drugs mentioned

• Alpha-Cyclodextrin (alpha-cyclodextrin)

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Cardiovascular Disease | Phase 2 | Status: COMPLETED | Results posted: 2016-10-21